Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minh Deo

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|May 1, 2019
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor AgonistsGirdhar Singh Deora, Cheng Xue Qin, Elizabeth A Vecchio, et al.
Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 7, 2026
Sex-Specific Responses in the Early Stages of Diet-Induced Cardiovascular-Kidney-Metabolic SyndromeAbhipree Sharma, Minh Deo, Kevin Tran, et al.
Journal of Sport and Health Science|October 16, 2025
Influence of diet-induced obesity and voluntary exercise training on cardiac lipids and mitochondrial function in miceNimna Perera, Minh Deo, Surafel Tegegne, et al.
Cardiovascular Drugs and Therapy|February 17, 2020
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Cardiovascular Drugs and Therapy|October 27, 2019
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Iscience|September 22, 2023
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathyCharles D Cohen, Miles J De Blasio, Gabriella E Farrugia, et al.
Cardiovascular Diabetology|June 2, 2021
Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular compositionCharles D Cohen, Miles J De Blasio, Man K S Lee, et al.
Frontiers in Pharmacology|April 20, 2019
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac<sub>2-26</sub>, Against Myocardial InfarctionCheng Xue Qin, Sarah Rosli, Minh Deo, et al.
Nature Communications|February 8, 2017
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in miceCheng Xue Qin, Lauren T May, Renming Li, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|May 1, 2019
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor AgonistsGirdhar Singh Deora, Cheng Xue Qin, Elizabeth A Vecchio, et al.
Cardiovascular Diabetology|November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunctionTing Fu, Muthukumar Mohan, Madhura Bose, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 7, 2026
Sex-Specific Responses in the Early Stages of Diet-Induced Cardiovascular-Kidney-Metabolic SyndromeAbhipree Sharma, Minh Deo, Kevin Tran, et al.
Journal of Sport and Health Science|October 16, 2025
Influence of diet-induced obesity and voluntary exercise training on cardiac lipids and mitochondrial function in miceNimna Perera, Minh Deo, Surafel Tegegne, et al.
Cardiovascular Drugs and Therapy|February 17, 2020
Correction to: The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Cardiovascular Drugs and Therapy|October 27, 2019
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic HeartMitchel Tate, Gavin C Higgins, Miles J De Blasio, et al.
Iscience|September 22, 2023
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathyCharles D Cohen, Miles J De Blasio, Gabriella E Farrugia, et al.
Cardiovascular Diabetology|June 2, 2021
Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular compositionCharles D Cohen, Miles J De Blasio, Man K S Lee, et al.
Frontiers in Pharmacology|April 20, 2019
Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac<sub>2-26</sub>, Against Myocardial InfarctionCheng Xue Qin, Sarah Rosli, Minh Deo, et al.
Nature Communications|February 8, 2017
Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in miceCheng Xue Qin, Lauren T May, Renming Li, et al.
Pageof 4